[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![Sarepta Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::2216555822.png) Sarepta Therapeutics [@Sarepta](/creator/twitter/Sarepta) on x 6162 followers
Created: 2024-12-18 13:37:50 UTC

Today we announced that enrollment & dosing is complete in Study SRP-9003-301, a Phase 3, multi-national, open-label study of investigational candidate SRP-9003 for the treatment of LGMD2E/R4. Data are expected in the first half of 2025.

![](https://pbs.twimg.com/media/GfFcBKuXMAAS9nR.jpg)

XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1869376529836503101/c:line.svg)

**Related Topics**
[sarepta therapeutics](/topic/sarepta-therapeutics)

[Post Link](https://x.com/Sarepta/status/1869376529836503101)